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Abstract 
This project’s goal was to determine whether our device idea could create a viable business. 
The electrocardiogram, a cardiovascular monitoring device, frequently becomes tangled, 
unorganized and less accessible to our end users. For a convenient set-up process, our device will 
solve these problems by allowing for the electrode leads to be wound up into the storage 
accessory, maintaining consistent organization, along with simultaneous sanitation. We 
accomplished this by researching proper information, validating our research with professionals, 
and conducting a feasibility analysis to determine commercialization potential. We concluded 
that our device would not create a viable business at its current state of functionality rather 
showing promise for a potential licensing deal. We created a year-long development plan for 
further commercialization. 
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Executive Summary 
 
The electrocardiogram is a medical diagnostic device used to study the electrical and 
muscular functions of the heart. Whenever a patient shows any symptoms of having trouble 
breathing, chest pains, or a history of hereditary heart disease, an EKG test is usually called for. 
The end user of an electrocardiogram needs an organized configuration to get a successful 
reading as soon as possible. Our electrocardiogram accessory would help in maintaining a 
consistent organized set up, as well as both features of retractable electrode leads and 
simultaneous sanitation upon storage. 
Goals and Methods 
Our main project goal was to analyze the feasibility of starting a business from our 
medical device. To find out if our product was of commercial value, we had multiple objectives 
that needed to be accomplished. First, we had to research substantial background information. 
Afterwards we conducted interviews of medical professionals, collected surveys, and observed 
the medical setting to validate research, and further assess our commercialization potential. 
Participants in our customer discovery research ranged from registered nurses, doctors, nurse 
educators, nurse managers, biomedical engineers, hospital management, patent professionals and 
purchasing agents. This data collection allowed us to make a well-educated decision on the 
ability of starting a business. Our next step was to develop a commercialization plan for our 
device, which would revolve around the finalization of our design concept, intellectual property, 
the market condition, manufacturing costs, and potential medical device manufacturers. Upon 
conclusion of the method of commercialization, we entailed our recommendation for the 
Retractable EKG Wiring Unit’s future development. 
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Results 
 After researching all of our deciding factors for creating a business, we were able to then 
analyze our results for future decision making. From our customer validation, we confirmed that 
there was a need for our device in the hospital setting as feedback from our end user was highly 
positive. With that being said, the medical device market was discouraging for potential market 
share, and was very competitive for direct sale distribution into hospitals. When interviewing the 
purchasing personnel of hospital management teams, we found that decision making for direct 
sales, as a vendor, to hospital was a very dynamic and time consuming process. We also 
discovered very quickly that new vendors are rarely negotiated with as larger established 
companies have a vast advantage in what they can offer.  
Our next plan of action after ruling out a direct sales commercialization strategy was to 
evaluate potential intellectual property for our device, in order to consider a licensing deal. As 
our device was not made fully functional in our engineering phase, we were not able to pursue a 
utility patent. We did confirm that we had intellectual property, and applied for a provisional 
patent. This allowed us a period of 12 months to engineer a fully functional minimum viable 
product in a research and development phase and gave us a clear path of our strategy of 
commercialization. 
Conclusion & Recommendation 
 We concluded our project goal of creating a business with our device was not feasible, 
however, it did have potential for a future licensing agreement. With our provisional patent, we 
plan to initiate a yearlong development plan in which a functional minimum viable product will 
be engineered. Once the MVP is solidified, a utility patent can be applied for, prior to soliciting 
medical manufacturers for a potential licensing contract agreement.  
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1.0 Introduction  
 The goal of this Major Qualifying Project was to answer the question, “can our product 
idea create a viable business?”. The product in question for our project was a retractable wiring 
unit for an electrocardiogram, that would offer a decrease in setup and storage time due to 
mechanically assisted wire coiling and automatic sanitation. In order to answer this question in 
its entirety, there were a few deeper, more systematic questions that needed to be answered. 
Starting a new business is not just one task, but a multitude of tasks, whose outputs come 
together to form what will, or will not be, a sustainable business. First, we discovered the 
feasibility of entering into the market with our device. Whether market penetration was feasible 
relied on a few factors. The main factor was whether or not the product trying to enter the market 
provided for a need, or fixed a particular problem. In other words, would somebody buy this 
device for its potential benefits and application? Aside from end user acceptance within the work 
environment, market penetration success depended on how difficult it would be to sell a product 
to a hospital. Discovering the answers to both of these concerns allowed us to transition to the 
next question. Depending on our market feasibility results, what is the best method of 
commercialization? Devising a plan on how to bring the device to market relied on whether a 
hospital or manufacturer would buy the product, and how difficult it was to sell to the end users 
and customers being targeted. Ultimately, deciding on a method of commercialization translated 
into how our new venture would sustain itself in sales, what our business model would be, and 
thus answered our question, “can our product idea create a viable business?”. 
 Our product idea was an organizational accessory to assist the consistent storage and 
sanitation protocol for the lead wires of an electrocardiogram machine. An electrocardiogram, 
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also called an ECG or EKG, is a device used to observe and analyze the electrical and muscular 
functions of the heart for further diagnosis. An electrocardiogram consists of ten different 
electrodes that are placed on various parts of the body to detect electrical impulses generated by 
the heart. The mechanical parts of the machine consist of; the electrocardiogram itself, a ten pin 
plug to connect to the ten different electrode wires, and the electrodes and corresponding wires.  
 Often times when an electrocardiogram is used, wires can get tangled and mixed up due 
to the lack of post use storage quality and care. It is not only an inconvenience to the doctor or 
nurse that is using the machine, but could also pose a hazard to patients in need of time pressing 
examination, when time needed to untangle and re-organize simply isn’t available. Our device 
aimed at improving a few aspects of the device use. First, was to improve set up time and put 
away time by neatly storing the wires in their own spools, while also running the wires through a 
disinfectant soaked sponge while being cranked into storage. Second, was to improve the 
consistency of the quality at which the machine was stored every time after use. It would 
guarantee a perfect put away every time, along with a guarantee that the wires were disinfected 
every time as well.  
  The two precursor questions needed to meet our main goal were, was market penetration 
feasible, and what commercialization method was best? This project was broken up into three 
different phases of action to accomplish the objectives that assisted us in answering the two 
precursor questions. The phases were completed in a systematic way to logically determine 
whether we could create a viable business.  
 The first phase of action completed was our “Research” phase, with the objective of 
completing all literature research needed to accurately develop our product, and also accurately 
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hypothesize market penetration and eventually our commercialization method. These topics 
included how electrocardiograms function and their operational process, intellectual property 
rights, regulations, market research, hospital operational structure and decision making process, 
and ways in which to finance a new venture. These concepts did not only set a solid foundation 
of knowledge for our venture to develop on, but it also laid the groundwork toward answering 
our precursor questions. Market penetration feasibility was determined by how our device would 
work with already existing electrocardiograms, how strong our intellectual property was, and 
how a hospital made the decision to purchase an item. The sales method for commercialization 
was to be decided pending those answers 
 The second phase of action performed was our “Customer Discovery and Validation” 
phase. This phase had the objective to recapitulate and answer the former precursor questions 
and validate our literature research by using the “Customer Discovery” methodology created by 
famous entrepreneur, Steve Blank. His methodology encourages the founders of a new venture to 
hypothesize who the customers and end users of the product are, and hypothesize the various 
operations and sales strategies that the founders “think” will work to drive their venture. The 
chosen methodology uses Alexander Osterwalder’s “Business Model Canvas” as the primary 
organizational tool to record and test the various hypotheses, which is what we used as our 
primary organizational tool as well. Using Blank’s methodology, along with the canvas, we 
interviewed a number of people, consisting of medical professionals, biomedical engineers, and 
intellectual property professionals. The interviews validated our product with feedback from the 
hypothesized end user, and also tested our previous literature research, regarding the way in 
which hospitals make a decision to purchase an item. With the new information gathered, we 
were able to make a logical decision on the feasibility of penetrating the market with our 
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accessory, and subsequently allowed us to have a clearer vision of how to further commercialize 
our device. 
 The third and final phase of action for meeting our goal was the “commercialization 
plan” phase. The objective of this phase of action was to analyze our results from all the 
information that was gathered from both the literature research and interview data, and construct 
a plan for further commercialization. There were two ways for our product to enter the market, 
and that was a direct sales method to the hospitals, or obtaining a licensing agreement with an 
established electrocardiogram manufacturer. Making a decision on the two options depended on 
our final conclusion regarding the feasibility of market penetration with our device, which relied 
on end user acceptance, intellectual property strength, and how welcoming the hospital 
purchasing process is to new vendors. The final commercialization method chosen gave us the 
answer we were searching for pertaining to our original question, “can our product idea create a 
viable business?”. If we were able to choose the direct sales method of entering the market, then 
yes, our product could have a run at creating a viable business. If we concluded that obtaining a 
licensing agreement with an established manufacturer was the best route for commercialization 
of our device, then our answer would be, no, due to the fact that licensing the device for the 
manufacturer to produce is technically not a business.  
2.0 Background 
 The overall goal of our project was to find out whether our product idea could be formed 
into a viable business. To discover whether a business could be formed, we determined if 
entering the market would be feasible, and what strategy of commercialization would best suit 
our venture. To hypothesize feasibility and a commercialization method, topics that we needed to 
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research included electrocardiogram components and protocols, the structure of decision making 
operations within hospitals, intellectual property, and finance options. Alexander Osterwalder’s 
business model canvas was used as a visual tool to begin organizing our hypotheses created 
while conducting our background research.  
2.1 Electrocardiogram Machine  
 An electrocardiogram is a significant instrument found within all Emergency Rooms and 
doctor's offices. The electrocardiogram (ECG or EKG) is a diagnostic tool that is routinely used 
to assess the electrical and muscular functions of the heart (EMT Resource, 2014). An 
electrocardiogram is easy and simple to use, but the interpretation of the results requires a great 
extent of education and training. There are three main components to the machine; the 
instrument itself, including a monitor of some sort and the electronics of the machine, a specific 
number of wires to connect to separate electrodes, and the electrode pads. This device measures 
the rate and rhythm of a heartbeat, but can also give slight insight to heart blood flow.  
 The standard electrocardiogram has 10 wires, to produce 12 leads, or a signal of electrical 
activity. As you can see in Figure 1 below, each wire is typically color coded to represent the 
various parts of the body to be connected to the corresponding electrode pad. There are 4 main 
extremity leads, which include a wire to the left and right arm, a neutral wire that gets stuck to 
the right leg, and a wire for the foot on the left leg (Garcia, 2015). The last remaining 6 wires get 
placed on various, specific parts of the chest. There are a variety of other types of machines, such 
as a 10 lead, a 5 lead, and a 3 lead electrocardiogram (Vanderbilt, 2015). Since the 12 lead 
machine was the version we found to be most commonly sold by major manufacturers, we 
focused our device to be an accessory of a 12 lead electrocardiogram. See Figure 1 below for a 
typical 12- lead EKG machine. There is a consistency among the different manufacturers for 
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electrocardiograms in the way the 12 lead wires connect to the main cable of the device. This 
similarity was important, because it gave us insight on the type of features our prototype needed 
to have, and the placement of those various features.  
Figure 1 Electrocardiogram Machine 
 
 
 
 
 
 
 
  
 2.1.1 Proper Electrocardiogram Use 
The electrocardiogram is fairly straightforward in its operating procedure. The machine 
gets turned on, and the patient personal information is recorded for the hospital’s records. Once 
the patient's information has been logged, the nurse administering the electrocardiogram will 
untangle the wires if need be, stick the electrodes on the correct areas of the body, and place the 
color coded wire on the correct corresponding region of the body. See Figure 2 below for the 
standard chest positioning (Eldridge, 2014). The nurse then starts the machine and allows the 
program to take the reading. The results of the reading are then printed out, and a doctor is called 
upon to validate the results, and suggest further treatment if need be.  
  17 
Once the results have been validated by a doctor, the nurse unclips the wires from the 
electrodes, and throw away the electrodes. It is normal protocol to wipe down the individual 
wires with a disinfectant agent provided by the hospital. Once the wires have been disinfected, it 
is not specifically protocol, but common decency to wrap the wires in a neat fashion, instead of 
just bundle them in no specific fashion for the next person to use. The electrocardiogram 
machine is then plugged back into the wall to charge for the next person to use. 
The design of our device prototype relied heavily on this information for a few reasons. 
First, because the protocol shows there is a systematic way of putting on the leads to the patients. 
This meant that the placement of the wires in our device needed to tailor to this, and make sure 
that the wires were not stored randomly. Second, we understood that our device needed a way of 
sanitizing the wires before storage as well. This added a new feature onto our prototype idea, 
which was a compartment on the front of the box to hold a disinfectant soaked sponge. The wires 
would pass through slits in the sponge, cleaning the wires as they get wrapped up. This added 
more value to our device, other than the capability of consistent storage quality.  
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2.2 Organizational Structure of Hospital Operations and Decision Making 
 The operations within a hospital, which can also be classified as a large decision making 
process, are handled dynamically between the administration section of the hospital, and the 
clinical section of the hospital. The way these two sections interact is largely based on the type of 
hospital being referred to, whether the hospital is investor-owned or voluntary, or a freestanding 
hospital or a hospital that is a member of a multi-unit system of hospitals. Operational decision 
making within hospitals are constantly trying to determine, what benefit does the decision bring 
to the hospital as a whole, and who does it benefit, administration or clinical?  
Administration consists of trustees, administrators, voluntary staff physicians, hospital-
compensated physicians, and until recently, a growing number that involves nurses. These 
positions make up the major decision makers within the hospital, and are more likely to be 
Figure 2 Standard ECG Chest Electrode Positions 
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concerned with the decisions that pertain to the viability of the hospital itself. The clinical faction 
of the hospital consists of both the physicians and nurses of the establishment, and are primarily 
concerned with the decisions that will affect the care of patients. Administration is of course 
concerned about the quality of patient care, but focus mostly on management issues and 
allocation of resources, which in return are the driving factors for providing cost-effective care 
for patients. So although the goals of both sections seem to be different, one for monetary 
concern and one for care quality, both attempt to achieve an overall goal of affordable, quality 
healthcare for the patient, while also maintaining the viability of the hospital as a business. 
 “The most important point to understand about decision making in hospitals is that there 
is no single decision maker.” (Shortell, 2016). The decision making process within a hospital is 
very dynamic, with the input of several officials of the hospitals swaying the end decision. The 
representatives that assist in the making of the final decision of a given problem consists of 
physicians, nurses, executive level administrators, and middle level administrators such as 
department heads. Depending on the matter at hand, one of these groups of people may have a 
larger input to the matter then the others. For example, doctors have most influence over things 
like practice protocol, staff privileges, and determining whether a patient can be released or not. 
Upper executives influence mostly hospital policy and scheduling in relation to external forces, 
while lower executive, such as department heads, influence decisions regarding staffing, budget, 
and providing supplies for the particular department (Institute of Medicine(US), 1983). To deal 
with the conflicting interests and influences, two models of authority have been created. 
 The first model is the “Dual Authority Model”, developed by Pauly and Redisch and 
Harris (Shortell, 2016). This model divides the hospital into two main factions, the clinical side 
and the administrative side. The clinical faction of the hospital in this model has a large influence 
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on the daily operations of the hospital. The administrative faction of this authority model mostly 
exists to fulfill the needs the clinical factions’ operations, and supply the facilities, supplies, and 
equipment for their use. In simpler terms, this model associates the clinical faction with a more 
demand driven operation, and the administration with a more supply driven operation, to provide 
for the needs of clinical. The second model is the “Shared Authority Model”, which involves a 
more even decision making process between clinical and the administration, with more 
involvement of clinical and administrative data to better validate the decision (Shortell, 2016). 
This model is a bit more complex, and was derived through external societal and economical 
forces. 
 This research assisted the development of our project by helping us answer, how feasible 
is market penetration? The feasibility not only depended on end user acceptance, but also 
depended on the difficulty of convincing a hospital to purchase our device. By understanding the 
complexity in the process of decision making that is standard to hospitals, it put in perspective 
how difficult it would be to sell directly to these establishments. Along with assisting in the 
realization of how feasible entering the market was, it also gave insight to how we were going to 
potentially commercialize our device. 
 Commercialization for our venture consisted mainly of what form of “sales” was to be 
made, in order to generate a cash flow. For our venture, we hypothesized that sales would either 
be generated by directly selling to a hospital, or obtaining a licensing agreement with an already 
established electrocardiogram manufacturer. This evidence helped us to get an early idea as to 
what our commercialization method may consist of.  
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2.3 Intellectual Property 
Proper protection of our intellectual property for our device was explored to determine 
whether we use a direct sales method for our device, or obtain a licensing agreement to obtain 
sales. When an inventor or any person representing an inventor's idea, wants to protect their 
intellectual property, they apply for a patent. If two or more people make an invention together, 
they would apply for a patent as joint inventors. A person who contributes only financially is not 
considered as a joint inventor, nor can he or she be joined in the application as an inventor. It is 
not difficult to omit or add a person as a joint inventor.  
2.3.1 Patents 
“A patent for an invention is the grant of a property right to the inventor, issued by the 
United States Patent and Trademark Office” (USPTO, 2014). Once a patent is granted, the patent 
owner has the legal authority to exclude others from making, using or selling the invention in 
that country without a license. A provisional patent can be issued and held for one year before a 
decision is made to further pursue a utility patent. A utility patent is a form of protection that 
“may be granted to anyone who invents or discovers any new and useful process, machine, 
article of manufacture, or composition of matter, or any new and useful improvement thereof” 
(USPTO, 2014). Patenting is an expensive process and depends on the type of invention you 
intend on patenting because attorney fees, as well as the patent search prices increase with more 
extensive inventions. Attorney prices range from $5,000.00 - $16,000.00 and patent search costs 
typically range from $1,000 - $3,000 dollars based on complexity. 
The United States Patent and Trademark Office (USPTO) has offered inventors the 
option of filing a provisional patent application instead of the utility patent process. This was 
designed to provide a lower-cost initial patent filings. However, the attorney fees are still roughly 
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$2,000 to go along with a $130.00 filing fee. A provisional application provides the ability to 
begin on an early effective filing date in a patent application and permits the term “Patent 
Pending” to be applied in conjunction with the invention. Provisional applications may not be 
filed for design inventions.  A provisional patent is the smartest way to acquire intellectual 
property protection before you are certain you will be carrying out your business venture.  
2.3.2 Licensing 
Licensing a patent was one of our two options to commercialize our invention. A patent 
license agreement is simply “nothing more than a promise by the licensor not to sue the licensee” 
(USPTO, 2014).  Licensing our product to a manufacturer was a viable option once intellectual 
property was confirmed as the invention could have been sold to a manufacturer in multiple 
capacities of licensing agreements. The licensing contract agreement could be an upfront price or 
the inventors could receive royalties off of future sales of the influenced product. Some specific 
differences of agreements that we became aware of were whether it was an exclusive licensing 
agreement, non-exclusive agreement or if it was exclusive in certain territories. An exclusive 
licensing agreement entails that no person or company besides the named licensee could 
potentially exploit the intellectual property right, as well as the licensor who is not allowed to 
exploit the intellectual property even after an agreement is made. A non-exclusive licensing 
agreement allows the licensee the right to use the intellectual property, however the licensor 
remains free to sell the same intellectual property to any other licensees. When soliciting a 
licensing deal with companies it was apparent that an attorney or licensing agent should be 
present when going through the legalities of the contract in order to make sure a fair deal was put 
in writing without any loopholes or hidden connections.  
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2.4 Finance Options and Expenditures 
2.4.1 Raising Start-up Capital 
Any new business venture will need to decide how they are going to initially fund their 
business operation. There are many avenues in which capital can be secured and they are based 
upon the type of business being assembled, the amount of funding needed, the type of funding, 
and how to secure these finances. Understanding the options available will assist in making 
smart decisions to raise start-up funds in the early stages of our business. 
There are two main types of financing for a potential new business venture, including 
debt financing and equity financing. Debt financing is when an investor provides you with a 
given amount of capital which must be repaid in a certain agreed upon manner. The loan is paid 
back in its entirety plus interest, which is a fixed value upon agreement. Investors benefit in the 
deal only by the interest accrued over time, and the business gets the necessary capital to start 
their venture. Debt financing can be cash flow based or asset based depending on the financial 
position of the new business founders. Cash flow debt financing involves strictly cash received 
by the venture in the course of their business successes. No assets of sufficient value are 
collateralized to pay off the loan. The financial institutions that offer cash flow based debt 
financing normally will require that the new venture has had consistent cash flow for some time 
and has promising future expectations, with evidence that the income will be continuous through 
the term of the loan. In order to lower risk the lender may add stipulations or covenants, which 
are requirements that must be followed or the investor may relinquish the deal or fine the 
business venture (Bussgang,1989). This is only to ensure that they will not be at a loss and will 
get their capital back if the business struggles. Asset based debt financing is used for businesses 
that do not have a history of a consistent cash flow, however have some valuable asset or 
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property to offer, if their debt cannot be repaid. This is called a lien, which gives the rights to the 
possession to the lender in the event that the agreement is not fulfilled.  
 Equity financing is very different from debt financing as the equity investor provides an 
amount of capital to the business venture in exchange for an agreed upon share of ownership. 
The equity investor shares in the ventures upside value creation and is also at risk for losses. 
There is no ceiling for the return on investment by the equity investor as they own a share of the 
business permanently. As this potential can be great investors are more willing to take part in 
riskier ventures with large upsides than a debt investor would normally be. This higher risk of 
investors also increases their demand of higher return on their capital investment (Bussgang, 
1989). Equity investors are usually professionally managed firms whose business is investing in 
new ventures, asserting managerial control through positions on the company’s board of 
directors, where they can make decisions as well as monitor the businesses performance. 
The sources of funding that are available for new business ventures include self-funding, 
personal credit lines, crowd-funding, venture capital groups, angels and accelerators. Each of 
these sources have different characteristics that can be beneficial to a start-up, but it all depends 
on the particular business’s position and needs, and the demand for investors to pursue a 
promising deal. The venture capital industry is an exclusive and small industry with about a 
thousand investors in the country. These are very well off companies that can provide capital to 
high risk ventures, even when they have uncertain outcomes and long pay-out periods. Venture 
capital groups will not usually fund small start-up costs for entrepreneurs, rather looking for 
potential breakthrough business ideas, typically technology based, that require a significant 
amount of money to get up and running (Schaufeld, 2015). Venture capital groups will look 
deeply into the infrastructure of the start-up to see if the right pieces of the puzzle are present to 
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create a profitable and efficient business. The start-up venture must have a clear vision and must 
demonstrate that they are a good buy for a venture group to invest.  
Angel investors are individuals or groups of individuals who have cash to invest as well 
as expertise in certain markets of business, and are usually able to help entrepreneurs in business. 
Angel investors want to see a return on investment but are also interested in helping run 
businesses and launch successful start-ups. Angel investors are important sources of funding as 
they are more willing to deal with smaller investments that venture capital groups may pass on 
(Schaufeld, 2015). 
Crowd-funding is another source of venture funding in which a large number of people 
can invest small amounts of capital in a business, which gives the business valuable capital that 
may have been too small for venture capitalist or angel investor. Crowd-funding allows the 
investors to obtain either equity in the business they invest in or receive a non-equity token, 
which can be anything of value that the business has, for example, a product sample, a special 
service or recognition (Bussgang, 1989). 
Accelerators are an emerging source of funding where the organization gives a new 
venture cheap office space, coaching and mentoring to a business as well as some equity based 
financing, to “accelerate” a business into the market and towards their goals (Schaufeld, 2015). 
Accelerators can be very helpful for new business ventures with limited connections and 
experience by helping to connect them with advisers and experts that are otherwise difficult to 
get in contact with.  
Lastly, a start-up could receive non-dilutive financing, which is ideal for the early 
development of technology and other intellectual property, especially in an academic 
environment. Non-dilutive financing is usually in the form of government grants and is 
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extremely helpful for the research stages of development that could be very expensive for a start-
up company. This allows for pivots and trial and error in research without the expectations of an 
investor or the inability to afford continuing research. 
 All of these sources of funding are viable options for our new business venture. Finding 
the right deal and the right team to work with is essential in creating a successful start-up, and 
the source of your business’s funding is inevitably one of your most important business partners. 
Our business will need to decide on the most reasonable and complete plan to raise capital and 
get our business off of the ground.  
2.4.2 Production Costs 
In order to understand production costs, our business must understand the laws of supply 
and demand. A firm would be willing to produce a certain amount of goods based upon the 
demand of consumers, and the price they are willing to pay in order to strategically supply a 
product with the economic goal to maximize profits (Bruns, 2004). Total revenue is the amount a 
firm receives for the sale of its output. Total cost is the market value of the inputs in which is 
used in production of goods. Hence, profit equals the total revenue minus the total cost. Costs of 
production can be divided into fixed costs and variable costs as fixed costs are those that do not 
vary with the production quantity, and variable costs do vary with the quantity of production. 
Total cost equals both total fixed costs plus the total variable costs, however, it is also quite 
important to be cognizant of the time frames that are being forecasted as in the short run fixed 
costs remain fixed, while variable costs keep their characteristics, but in the long term fixed costs 
become variable costs as production processes change over time (Bruns, 2004).  
  27 
Another useful production cost a company should be aware of is its average costs. 
Average costs of each unit can be calculated by dividing the firm’s costs by the quantity of 
output produced. The average cost of each good is the typical cost of each unit produced. It still 
takes into account fixed and variable costs just as the total costs are calculated. Average total 
cost equals the sum of both average fixed costs and average variable costs. When diving deeper 
into a firm’s cost of production it is important to know that this includes all of the opportunity 
costs of creating its output of goods and services, more specifically involving explicit and 
implicit costs (Schaufeld, 2015). Explicit costs are the input costs that will require direct cash 
from the company, whereas implicit costs are input cost that do not require expenditures by the 
company. When total revenue exceeds both implicit and explicit cost, then profits will be earned.  
This leads us to the production function which shows the relationship between quantity of 
inputs used to create the product, and the quantity of output of that product. The marginal 
product of any input in any production process is the increase in output that arises from an 
additional unit of that input. To decrease the means in which a company could produce another 
unit of output, either another worker is hired or an increase in input capital, allowing an 
additional unit to be created for a smaller cost. This can be seen in the marginal product equation 
which equates to the change in Y over the change in X. Where the change in X is the change in 
the firm’s input use, and the change in Y is the change in quantity of output produced, resulting 
from the change in input. Following the law of diminishing marginal product, the marginal 
product will begin with an increase, however it will reach a point where the additional increase 
of input will either remain the same or it will decrease marginal production (Bruns, 2004). 
Marginal costs measure the increase in total cost that arises from an extra unit produced. This 
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helps the company to understand for each additional unit produced, how much that unit will cost 
and how pricing can or should change. Because marginal cost rises with the amount of output 
produced it reflects the property of diminishing marginal product. 
Understanding the relationship between marginal costs and average total costs can help 
greatly when analyzing the trajectory of your average total cost. For example, whenever the 
marginal cost is less than the average total cost than the average total cost is falling, whereas 
whenever marginal cost is greater than average total cost, average total cost is rising. For a 
company, its cost reflect its production process as described in the various relationships above. 
When creating our proforma financial statements, a keen understanding of the noted financial 
tools will be vital to accurately project our start-ups finances. This analysis will also be essential 
to have for our day to day use in decision making as a business and future choices as a company. 
Planning for years in advance is necessary when starting your business and we will be looking 
extremely close at our financial data when it comes to our ability to have annual success as an 
organization.  
3.0 Methodology 
 The main research goal of this project was to analyze the feasibility of creating a business 
with our device. In order to achieve this goal, we completed three phases of action that would 
allow us to accomplish certain objectives that would assist us in meeting our goals. Our first 
objective was to obtain extensive information in our “research” phase needed to accurately 
develop our product, and accurately hypothesize market penetration, following with our 
commercialization method.  
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 Second, we conducted professional interviews and surveys as a part of a “customer 
discovery and validation” phase, with the objective to validate our primary literature research, 
along with validating our hypotheses regarding the answers to our goal questions and end user 
information. This adhered to the methodology of Steve Blank, by seeking the feedback of 
medical professionals, hospital management staff and intellectual property experts regarding our 
device.  
 Third, a “commercialization decision” phase, with the objective to evaluate all the results 
of the previous objectives, and make a logical decision on what our commercialization method 
should have been. In order to achieve these objectives, we used all resources available to us 
including online research, WPI databases available, and professional surveys and interviews. 
This section explains our methodology in detail for each objective we sought to fulfill, in order 
to reach our project's goal.  
3.1 Phase 1: Research 
 
Objective 1: Gather literature to accurately develop our product, and accurately hypothesize 
both market penetration feasibility and a commercialization method.  
3.1.1 Background Research 
Our literature research was our overall first step towards answering our research goal. It 
was important for us as a new venture to be extensively educated on the electrocardiogram, being 
the device that our product is an accessory for. We also needed to become very familiar with the 
business environment we were attempting to enter and to identify and understand the various 
options we would be faced with while constructing our business. We achieved this by searching 
the library databases and all literature we could obtain in order to make our initial assumptions 
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on what it took to start a business and commercialize our device. The databases used that were 
available through the Gordon Library of WPI consisted of sites such as PubMed, ScienceDirect, 
JSTOR, IBIS World, and Google Scholar 
 3.1.2 Market Research and Industry Reports 
In order to enter the medical device industry, we thoroughly investigated the current 
market conditions and industry reports. The industry reports and market data were retrieved from 
IBIS World, being an industry report database available to us through the school. Other pieces of 
data, such as number of hospitals, employment number of various medical professions, and 
annual wages, were obtained through the U.S Bureau of Labor Statistics, and the American 
Hospital Association. We identified all aspects of the medical device industry including barriers 
to entry, regulation level and the rate of technological change amongst other facets of the 
industry. This research allowed us to construct the value analysis of our product for our customer 
and end user.  
 3.1.3 Manufacturing 
For our project it was essential have an in-depth understanding of the type of materials 
needed, their price and costs of production. We roughly priced the cost of materials by the 
individual unit through an online materials vendor called OnlineMetals.com, as well as 
calculated the cost of manufacturing using the average salary of a machinist the United States. 
We then received an official quote from an IPG photonics material supplier which gave us a 
better understanding of potential pricing for the retractable EKG unit. 
 3.1.4 Intellectual Property 
Intellectual property rights were very important for us regarding the protection of our 
idea when it comes to production. The procedure in which to file for a patent needed to be 
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understood, and the specific options available needed to be considered carefully. We researched 
these procedures through the United States Patent and Trademark Office website, along with the 
costs involved with filing for a patent. A patent protects our intellectual property from other 
manufacturers or businesses, and give us options when determining what kind of sales we are 
going to try and achieve. Whether we used a direct sales method or receive royalties through a 
licensing agreement with another company, having a patent for our device was the first step in 
any one of those processes for the utmost protection. We assessed the use of a provisional patent 
to protect our device as more commercialization feasibility analysis unfolded.  
 3.1.5 Major EKG Manufacturers 
In the event that licensing was the best option for our business’s success, we needed to 
research the manufacturing companies for EKG machines, and how we could potentially license 
with these companies. It will be pivotal to find which companies license the most regularly and 
by what agreements and terms. These manufacturers business tendencies will clearly define our 
path of licensing and will help clarify our new business venture’s path. Manufacturers were 
contacted in attempt to gain information on licensing procedures of individual companies. This 
research will help us prepare for existing competitors in the market as well as what to expect in 
licensing our product. 
3.2 Phase 2: Customer Discovery and Validation 
 
 
Objective 2a: Validating our literature research by using Steve Blank’s “Customer Discovery” 
methodology. 
Objective 2b: Confirm market penetration feasibility through Steve Blank’s methodology as 
well.  
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3.2.1 The Business Model Canvas and the Methodology of Steve Blank 
The Business Model Canvas created by Alexander Osterwalder was our primary 
organizational tool to put together the various aspects of our new potential business. Along with 
the canvas, we utilized the Customer Development methodology founded by Steve Blank, a 
Silicon Valley serial-entrepreneur and entrepreneurship professor at a number of universities. 
Using the canvas, Steve Blank’s methodology encourages the business founders to take guesses, 
or hypothesize, what their business entails, and what kind of customers will the business be 
generating revenue from. The main purpose of using the Customer Development methodology 
was to discover who exactly our customers and end users were, and validated our own ideas by 
understanding what these people do every day in their workplace, and get a first-hand look at the 
everyday challenges they face. We used this approach to help answer a few questions for our 
research goal by validating our literature and expanding upon the data by backing up our 
findings with hospital specific personnel.  
3.2.2 Hypothesize and “Get Out of the Building” 
Using the Business Model Canvas and Steve Blank’s methodology, we started by 
hypothesizing what sort of content would be placed in each of the 9 boxes of the canvas (Refer to 
Appendix C).  Our hypotheses consisted on who our end users would be, who our customer most 
likely was (in our case the end user and the customer were two different people), prove whether 
direct sales could work in a hospital setting, and determine whether there was a need for our 
device. 
 Once we made the hypotheses for our canvas, we then planned our strategy to “get out of 
the building”. This entailed first, compiling a list of contacts that would allow us access to the 
sections of a hospital that we expected our end users and customers to be in. The created list was 
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compiled of anyone, family or friends, that would allow us to get our foot in the door, and be 
used as a stepping stool towards meeting new people. Our new candidates were derived through 
networking with the original professionals being interviewed, and sought contact information of 
the people they knew that would be beneficial for us to interview. 
We then proceeded by setting up appointments to be able to interview these various 
professionals, whether it was in person or through a tele-communication program and web cam. 
Having an in person interview was our main goal when setting up the appointments, but 
scheduling and location can often be difficult factors to work around. (Refer to Appendix D for 
interview questions) 
 Aside from listening to the chosen professionals we interviewed, the goal of our face to 
face interviews was to be able to get into the workplace. This enabled us to observe for ourselves 
the environment being worked in, and link key points of our discussion with the interviewee to 
the actuality of the work environment. 
Speaking with the appropriate people including medical professionals, biomedical 
engineers, and management staff gave us real life feedback from our device’s end user, the 
decision makers in the hospital, as well as the rationale behind product approval and product 
implementation. This was beneficial to our project because it gave us the opportunity to validate 
our previously done literature research. 
3.2.3 Test, Validate, and Revise  
 Through conducting our interviews, we had the opportunity to be able to test our 
previously hypothesized points for our Business Model Canvas. This “customer validation” 
showed us where we were right in our hypotheses, and where we were wrong. We were then able 
to take this information back for collaboration, and revise our canvas where it was needed. 
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This method of testing, validating through interviews, and revising our canvas was crucial to our 
education and insight on what our venture needed consist of, and also enabled us to gain 
knowledge that assisted us in decisions that required spending capital. This method first allowed 
us to identify our customer and our end user, and to determine whether they were the same 
person or not, considering that our end user and customer were going to be different people in 
the healthcare industry. We were then able to validate who we thought those people were, and 
were able to make changes and even add to that list of people on our canvas as needed. The 
interviews also gave us a chance to validate our value proposition with these customers and end 
users, and improve the value we bring based off first hand feedback from the people who matter 
the most to our business. This type of insight can save a new venture a good amount of capital, 
by not spending a bunch of money on a product that your customers may or may not like.  
 Validating our value proposition with our potential users and customers allowed us to 
tailor our product to have the attribute that the end user deems most valuable. This provides 
feedback for the feasibility of market penetration, considering that we received positive feedback 
from our end users about our device. If the end user didn’t like our device, we most likely would 
not be able to sell it to anyone. 
3.3 Phase 3: Commercialization Decision 
 
Objective 3: Designing our commercialization strategy. 
3.3.1 Determining The Best Avenue of Commercialization 
Commercialization for our device consisted of two options, whether we could sell 
directly to a hospital, or if we had to obtain a licensing deal with an established manufacturer. 
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Once our research and customer discovery was complete we were able focus in on the pivotal 
sections of our potential business using the knowledge acquired from our previous phases.  
After evaluating the results from phase 1 and 2, we were able to make a logical decision that 
licensing was the best path of commercialization. To pursue a licensing agreement from an 
electrocardiogram manufacturer, a strategic plan was made to overcome the unforeseen problems 
in functionality that our device encountered towards the end of our literature research, and into 
the beginning of our customer discovery phase. 
The development plan created was a yearlong project, using the time period a provisional 
patent would provide for further development of the device. We started this plan by applying for 
a provisional patent with the help of Todd Keiller, which guaranteed us a years’ worth of time. 
We then proceeded with the construction of a Gantt Chart, to map out the various tasks that 
needed to be done during the provisional patent period. We then determined that we would 
attempt to sponsor an MQP team to extend this project concept, giving us access to not only the 
resources of WPI, but being able to acquire the appropriate engineering students to overcome the 
design problems encountered. Assuming the MQP application with the school is successful, we 
used the terms of the academic semester of the school, and the corresponding weeks, to create a 
term by term, weekly plan. The plan compiled the necessary tasks to engineer functionality, 
create a marketing plan, and use that marketing plan to achieve the desired licensing agreement. 
 We came to this conclusion by analyzing our findings from the two previous objectives. 
Before our first phase, we automatically assumed that we would be able to do direct sales with 
any hospital that was interested with our product. Once our research was done through our first 
phase, we started to understand how difficult market penetration directly through a hospital 
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would be by studying the operations of a hospital and how the typically purchasing process was 
conducted. 
 When executing our second phase, we were able to validate our research pertaining to 
directly selling to a hospital, along with being able to receive direct feedback from our end users 
on our device idea, and what they would benefit most from. We received very positive feedback 
from a variety of emergency room nurses, EKG technicians in the emergency room, and two 
biomedical engineers we met. The feedback consisted of how useful the device could potentially 
be pending ease of use, encouraging how the tangling of wires is a legitimate issue, and also 
gave us the idea that adding a sanitation feature would be beneficial to the value of our device. 
Our research was validated when we had the chance to talk to various nurse managers, 
purchasing agents, and the biomedical engineers as well. The interviews with the 
“administrative” positions of the hospital allowed us to get a scope of how much of a process 
making a purchase was, and also how hospitals actually try to stay away from vendors of any 
kind. We came to the conclusion that market penetration was possible, but not through direct 
sales. We identified through the positive feedback from our end users that there definitely was 
potential in the market for our device, but no way we would be able to directly sell to a hospital. 
In order to further commercialize our device, we would have to obtain a patent for intellectual 
property protection, and seek a licensing agreement with a manufacturer of electrocardiograms 
that already has an established selling relationship with hospitals. The manufacturer would then 
incorporate our device into their design, adding value to their device as a whole, and we would 
receive a royalty for every machine sold with our device on it.  
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4.0 Results & Analysis 
 The goal of this project was to answer the question, “can our product idea create a viable 
business?”. By completing the systematic objectives described in our methodology, we were able 
to accurately determine our market penetration feasibility, and what our further 
commercialization method would be. We found that market penetration is feasible considering 
the extremely positive feedback received by our end users, but on the flip side, it would be a 
“marketing nightmare” to sell directly to hospitals. Based on that feasibility, we decided that 
obtaining a licensing agreement would be the best way to further commercialize our device. 
4.1 Objective 1: Research Results 
 After completing our literature research, we were able to hypothesize a few points about the 
environment we were trying to enter with our product. These hypotheses were:     
 Our end users of our device were going to be Registered Nurses, CRNs, and doctors.   
 Our customers within a hospital would be nurse managers and purchasing agents. 
 Considering the positive market conditions, and fairly low potential cost to produce one unit, we 
believed there would be a need for our device due to the money saved in time cut from the 
procedure. 
 That direct sale was an option depending on the value proposition we had to offer, regardless of 
how the operational structure was. 
4.1.1 Market Research  
 The total available market in the U.S was determined on how many registered hospitals 
in the U.S, which came to 5,686 registered hospitals The medical device manufacturing market 
in the U.S is an extremely competitive industry with typically high margins. The market is 
currently performing well and has been for the past 5 years, as in 2015, revenue is expected to 
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grow 1% to $44.2 billion and should continue to grow steadily to 2020 (Curran, 2016). With the 
economy’s improvement and an aging population, as well as expanded healthcare coverage and 
technology, the market should enhance with increasing hospital visits. Patient visits and their 
diagnosed need for medical device use are the supply chain for medical devices, and with their 
increase, the demand for medical devices increases. Specifically, in cardiovascular healthcare, 
the increased population of 65 years old individuals or older, who statistically have higher 
chances of having health issues that require medical devices, will continue to annually grow and 
increase hospital visits, and therefore so will demand for medical devices. The growing number 
of adults over the age of 65 also decreases trend risk score for the medical device industry, as 
you can see in Figure 3 (Curran, 2014). 
 
 
 
  
Cardiovascular devices make up 27.6% of the 44.2-billion-dollar medical device market and are 
second to none.  
 The Patient Protection and Affordable Care Act which was effective as of January 1st, 
2013, levies a 2.3% excise tax on the sale of all medical devices sold. (Curran, 2016) This 
obstacle could potentially inhibit innovation and the likeliness for investors to back medical 
device start-up companies as profits will take a hit for this tax. Along with this government 
Figure 3 Number of Physician Visits/ Number of Adults aged 65 and Older 
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excise tax, another risk in the medical device industry is the shrinking revenue industry wide 
which will cause more competition for the remaining market.  
This information further validates the market penetration feasibility we expect to take 
advantage of, but shows us how little of a market share there is within the industry. Also, the 
excise tax of medical device sales adds another, small, but valid reason as to why we would not 
do direct sales. 
4.1.2 Manufacturing 
  The first step in figuring out how to obtain a working prototype of our device was to 
engineer and design a 3D model using software on the computer to give a general idea of both 
component and assembly size. The dimensions decided upon through our engineering and design 
work was the first factor of costing that we were able to figure out. Pending the material, the 
proper dimensions would allow us to purchase the proper sizes of materials for creating a 
prototype. With those dimensions in place, our next step was to decide on a material that the 
device and all of its components would be made of.  
 The material choice needed to be medical grade, which in our case pertained to the 
porosity of the material, sanitation capabilities, and overall strength of the material. The porosity 
of a material is very important in the medical field due to the aspect of infection control. Porous 
materials can harbor bacteria growth due to the entrapment of certain liquids, especially water. It 
was important that the material chosen was not porous, to avoid the growth of bacteria, and avoid 
infection of any kind to anyone. Sanitation capabilities of the material pertain to the potential 
degradation that can be caused by using liquid sanitation agents on the material. A material 
needed to be chosen that would not degrade and erode on contact with these cleaning agents, in 
order to keep its’ form. The strength of the material also needed to be strong in order to assure 
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that there would be no breaks under any forms of stress. The stress exerted onto the components 
is minimal due to the function being performed, but we wanted to leave no possibility of the 
device breaking. 
 The two options of material “classes” we could use was either a medical grade metal, or 
medical grade plastic. We had two choices of medical grade metals that could have been used. 
These were austenitic 316 stainless steel and martensitic 440 or 420 stainless steel. Both 
materials would provide each separate attribute needed as stated above, but where very 
expensive.  
 Our second option was to pick from a wide variety of medical grade plastics. The Plastic 
that we chose is Ultra High Molecular Weight Polyethylene, or UHMWPE for short. The 
UHMWPE provided us with all of the necessary attributes such as water resistance, moisture 
resistance, micro-organism resistance, and resistance of most chemicals. The price of the 
material is much cheaper than the stainless steels also being looked at. An example of the 
difference in price between the two materials is, a piece of UHMWPE with the size of 
12”x12”x3”, a piece of material that can create a total of six component boxes, is roughly $120. 
A piece of austenitic 316 stainless steel with the size of 12”x4”x4”, which can create 6 
component boxes, but has roughly ½” of waste for each box made, has a cost of roughly 
$861.78. There is large difference in price between the two materials, so it is most practical for 
us to use the UHMW polyethylene plastic. 
 We received a quote from an IPG Photonics material supplier to see what the unit cost of 
the device would be when ordering parts in bulk. The estimated quote was for 100 sets of 
components that make 1 device per set, as shown in Figure 4. The material priced was the 
UHWMPE, with a unit cost being $22.84. This was a great example of how our unit price would 
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vary when buying in bulk. Refer to the table below from the estimate from IPG for component 
quantities and prices. 
 
 
 
 
 
 
 
 
 
 
4.1.3 Intellectual Property 
 Determining the strength of our intellectual property was one of the main driving 
components that would ultimately have a large impact on the future direction of our venture. Due 
to problems of functionality relating to engineering and design, Todd advised us that our idea 
was definitely feasible for commercialization, but needed to be fully functional. He assisted us in 
coming to the conclusion that our best move to have the opportunity to commercialize our 
product in any way was to take out a provisional patent. 
4.1.3.1 Provisional Patent 
 Due to the lack of functionality of our device, that is in relation to the unforeseen 
problems that arose while engineering our idea, Todd Keiller, Director of Intellectual Property 
and Innovation at Worcester Polytechnic Institute, advised that we file for a provisional patent. A 
provisional patent is a non-patent filing that allows the inventor to have a year's worth of time to 
protect the idea of the device, and allow the owner to set a date for the filing of the formal patent 
claim, with only having to give a description, and no designs or artwork of the invention. This 
Figure 4 Manufacturer Quote 
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years’ worth of time can be used for research and development, along with finalizing all designs 
and art that pertain to the invention at hand. For our venture, the provisional patent claim would 
give us a year’s time to further develop our product into a fully functional device, which would 
allow us to be applicable for filing a formal utility patent. A utility patent filed for a design that is 
not functional would be a useless action, considering that the device itself would never sell 
directly or be able to convince a company of a licensing deal anyway. The provisional patent 
would also be ideal for our particular situation, considering it costs only $130, as opposed to the 
issuing fee for a utility patent which is upwards to $480. We decided to follow through with 
obtaining a provisional patent in order to carry out our development plans for our device. (Refer 
to Appendix B). The provisional patent granted us a year to apply for a utility patent once the 
device is functional. 
4.1.3.2 Future Utility Patent 
 After taking the year that the provisional patent would grant us, to engineer our device to 
be fully functional, we would then file for the utility patent that is guaranteed to us after the 
provisional patent has expired. The utility patent gained by the end of that year would allow us to 
take the next step in commercializing our product. Having the utility patent will grant us ultimate 
protection of our idea and device, allow us to start manufacturing, and give us the freedom to 
proceed with obtaining a licensing agreement 
4.2 Objective 2a & 2b: Customer Discovery Results 
 The results of our customer discovery were able to validate who we thought our end users were, 
who our actual customers were, whether our device fulfilled a need, and validated whether a direct sales 
method as a vendor would be possible. We focused our research on purchasing decision making in the 
hospital, daily nursing protocols, proper electrocardiograph use, electrocardiograph use frequency, as well 
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as biomedical engineering analysis of products. With our customer and end user discovery results (see 
appendix E), we were able to make a majority of our future planning decisions necessary for creating a 
functional minimum viable product. 
 We were first able to identify who our actual end users would be. We were correct when 
hypothesizing that a registered nurse and a CRN were a part of that list, but completely wrong about 
doctors. We found out extremely soon that a doctor never actually uses an electrocardiogram machine, 
just assists in the reading and interpretation of the results. Instead, other positions such as a cardiologist, 
electrocardiogram technicians, and even an EMT would be considered our end users. 
 When assessing the value our product brought to our end users, we chose to travel to several 
hospitals in Massachusetts, as well as collecting separate interviews and surveys, in order to confer with 
as many medical professionals possible. There was an assuring amount of qualitative complaints 
regarding the traditional EKG machine set up being a nuisance to the medical professionals, as wires were 
frequently tangled, unorganized, and needed to be cleaned according to hospital code. Standard 
procedures for using electrocardiographs were discussed, explicitly how the typical set-up was, the 
current sanitation process, as well as protocol for transport of machines. We were also able to obtain 
quantitative data to complete our value analysis for our product including daily number of EKG’s taken 
by each interviewee, how much time it took setting up the machine, average time of successful EKG 
reading, and time elapsed for sanitation and storage (See Appendix D for data). The job descriptions of 
these end users ranged from registered nurses, cardiologists, CNA’s, EKG technicians, anesthesiologists 
and medical assistants. The feedback obtained from the medical professionals interviewed validated the 
need fulfilled and the pain eliminated that our product provides for the end user. 
 While visiting hospitals and continuing our customer discovery process we were able to speak 
with managerial positions pertaining to the purchasing decision chain, and the hierarchical structures of 
typical hospital management. We confirmed our literature review of the complex and time consuming 
relationship between the clinical and administrative sectors of a hospital. This knowledge was found by 
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speaking with nurse educators, nurse managers, biomedical engineers, and purchasing agents, from whom 
we received documents from their particular administrative manuals describing the different authorization 
levels of making a purchase. For example, in one medical center, non-capital items of services under 
$1,000 needed the approval of the department head, whereas items or services exceeding $1,000 needed 
to be approved by the department head as well as a VP board member. Additionally, we received a value 
analysis product request form which would be filled out by an employee, passed to their director, and then 
sent to purchasing for their review.  
Even with consent of the purchasing department, the biomedical engineers must also evaluate and 
approve the appropriate brand and model from the wide variety of established manufacturers, to 
determine the best choice for the hospital. The dynamic relationship between administration and medical 
professionals proved to be a large inhibitor of a direct sales approach for our product. An even larger 
obstacle was the reluctance of hospitals to change vendors and take on the risk of a product from a startup 
company. This feedback allows us to conclude that applying a direct sales based strategy would not be 
realistic for the commercialization of our device, and licensing would be a better option. 
 Once we validated that licensing was the best option of commercialization for our venture, we 
were able to answer our hypothesis regarding who our customers were. Since we determined that direct 
sales would not be a good option, we would not be targeting hospital administrates to sell to. 
Alternatively, our “customer”, would be the electrocardiogram manufacturer that we would seek a 
licensing agreement from. 
4.3 Objective 3: Commercialization Plan 
 We determined that the best way to further commercialize our device was to obtain a 
licensing agreement with an electrocardiogram manufacturer. Evaluating our intellectual 
property showed us that filing for a provisional patent was the best option for us to have more 
time to develop a functional device. This gave birth to our development plan for the twelve 
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months the provisional patent will be on file for, before having to file for a utility patent to be 
able to license. We constructed our plan by first designing a Gantt chart, with our time span 
being 52 weeks of time. We then made the decision to attempt to sponsor an MQP to have access 
to resources and engineering majors.  
 The schedule of the project is planned as if the MQP team was to take place in A, B, and 
C-term. A-term would be used to improve the design to achieve functionality. After the design 
changes, the group would seek customer validation from the end users originally contacted, and 
re-design the device tailored to the feedback received.  
 By B-term, the device will be tailored to be the best it can. During B-term, determining 
potential manufacturers to license to, and establishing a marketing plan for those manufacturers 
will be developed.  
 C-term would then be utilized to initiate the marketing plan devised, and obtain a 
licensing agreement, along with applying for a utility patent for when the agreement is 
determined. The provisional patent would expire within the first couple weeks of D-term, so 
starting in C-term to obtain a licensing agreement should be ample time. Also applying for the 
utility patent within the first week of C-term would allow for ample time to have the utility 
patent filed by the time the provisional patent is expiring. The Gantt chart and description of the 
development plan is located in Appendix A of this document. 
Conclusion and Recommendation 
Conclusion 
 In conclusion to our project, we were able to answer our research goal question, “can our 
product create a viable business?”, and the answer is no, it cannot. We concluded with this 
answer for two reasons. The main reason for coming to this conclusion is due to the fact that 
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hospitals just don't like to do business with new vendors, or an entity they haven't established a 
business relationship with. It would be a marketing nightmare, having to tailor to every group of 
people within a hospital operation that makes decisions. The time it would take to accomplish all 
of these sales pitches, just to find out they are out of the question would be a huge waste of time. 
Since we wouldn't be directly selling to our customer, instead licensing to an established 
manufacturer, we technically would not have a viable, self-sustaining business. The second 
reason we concluded with not having a viable business is due to our intellectual property. 
Although we decided that licensing to a manufacturer was the best method to further 
commercialize our device, we would not be able to obtain this licensing agreement without 
having intellectual property rights for a functional device. A manufacturer would not license a 
not functional device, and we wouldn't give away a device idea without assuring it wouldn't get 
stolen. 
 This project challenged us to utilize information from our course work at WPI. Being 
both management engineering students, we found ourselves referring back to our required 
business classes such as financial statements for decision making, marketing, creating value 
through innovation, and data analysis for decision making. Aside from the business curriculum, 
we were able to utilize 3D modeling and design, along with the entrepreneurship class 
“Launching new ventures”. This MQP fulfills the requirements for evaluating the competencies 
we have gained through our academic work. 
 
Recommendation 
 Our recommendation for this project is to follow the development plan created in order to 
further commercialize our device. This will be pending whether sponsorship of a new MQP team 
will be obtained. Although the conclusion of the project was that we did not have a viable 
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business, the yearlong development plan is a totally valid way to take the next step toward 
commercializing the device. 
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1.0 Assessment 
 
 The corresponding development plan is devised with the goal of developing functionality 
into the design of the retractable electrocardiogram wiring unit, obtain a utility patent, and 
license the intellectual property to an electrocardiogram manufacturer. After validating a 
potential market, unexpected functional problems arose during the final engineering and design 
of the device in order to file for a utility patent. Without using electronic modification to the 
EKG electrode lead wires, it was undetermined how the device would achieve the capability of 
adapting to a pre-existing electrocardiogram machine.  
 
2.0 Plan Overview 
 
 The development plan is set to run over the course of the next year, starting March 5, 
2016, finalizing the project by the same date of the next year. The provisional patent allots this 
time, starting on March 5, with a year until expiration. During the summer until the next school 
year, a sponsorship of a Master Qualifying Project at Worcester Polytechnic Institute will be 
applied for. Pending that application, the development plan intends to follow the the term 
schedule of WPI, with the project being accomplished during A, B, and C-term. The project team 
will consist of a mechanical, electrical, and management engineering student. 
  
2.1 A-term: 
A-term will be utilized by the mechanical and electrical engineering student to design 
functionality into the device to produce a tangible prototype, while the management engineer 
establishes contact with the previously interviewed end users for this device. After a rapid 
prototype is produced, meetings with the end user will commence, encouraging criticism and 
suggestions about the device. Recorded feedback will be utilized to redesign, and the 
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evaluation/validation will be iterated with the previously contacted biomedical engineers, to 
receive their professional evaluation. A final redesign will commence for the final weeks after 
the meetings have finished. 
2.2 B-term: 
B-term will take the now fully functional device and have the intellectual property re-
evaluated by Todd Keiller, director of intellectual property and innovation at WPI. The team will 
then commence with the proper paperwork and filings to start the 5-6 week process of obtaining 
a utility patent, which must be complete by the beginning of the next term. The remaining time 
of B-term will be used to determine potential electrocardiogram manufacturers to license to, and 
create a marketing strategy for each manufacturer. During the drafting process of the strategy, 
research, along with assistance from professors and advisors will help the team to set up the 
marketing strategy to be geared towards success. The group will have a final draft of the 
marketing strategy by the end of the term, and the utility patent will be fully completed and paid 
for the beginning of C-term. 
2.3 C-term: 
C-term will be the time to initiate the plan that is the marketing strategy. This is when the 
team will have to be most dynamic, keeping in mind that every company goes about handling 
business deals differently. Professional opinion from professors and advisors will be most useful 
during this time, which will better prepare the team for when the team talks to the companies 
over the phone. The first 30 second pitch with the right person over the phone could potentially 
lead to a more official business meeting, where potential real terms could be discussed. If an 
attempted company declines, changes to the marketing plan will be made, and the process will be 
started over with a new manufacturer. The goal by the end of the term, for March 5, 2017, is to 
obtain a non-exclusive licensing agreement with an established electrocardiogram manufacturer. 
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3.0 Development Resources 
 
 All previously gathered literature research and market data. 
 All established medical professional contact information, and previous interview results. 
 
4.0 Targeted Tasks and Goals 
 
This plan is in direct relation to the Gantt Chart displayed below: 
 
 March 5 - August 24 
o March 5, 2016: 
 Provisional patent filing is complete. This date starts the 365-day period 
until expiration. 
o March 15-August 24: 
 Call Worcester Polytechnic Institute, receive information from registrar 
regarding filing to sponsor a Master Qualifying Project 
 Application for MQP sponsoring will be filed for, proper fees and 
expenses will be paid. 
 Goals:  
 Complete process for sponsoring an MQP with WPI, be ready for 
the start of the new school year. 
 
 A-term: August 25 - October 13 
o Week 1 & 2 (start 8/29):  
 All team members engineer original design to incorporate functionality to 
the existing device. 
 Make edits to existing 3D models. 
 Goal of Week 1 & 2:  
 To obtain a functional device by the end of week 3. 
 
o Week 3:  
 Mechanical engineering and electrical engineering continue functional 
prototype design. Finish by end of week. 
 Use some form of rapid prototyping. Preferably a 3D printer on campus. 
Up to group discretion. 
 Management engineer begins arrangements (phone calls/email) to 
interview previously contacted end users.  
 Goals of Week 3:  
 Have a functional prototype completed for upcoming interviews. 
 Arrange a date and time with previous contacts, preferably during 
week 4.  
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o Week 4:  
 Attend arranged meetings with the end user to display functional 
prototype. 
 Allow the end users to evaluate the product, encourage ideas, and 
whatever input that comes to mind. 
 Record feedback, begin to determine what necessary changes need to be 
made while talking to contacts. 
 Goals of Week 4:  
 Complete all arranged meetings. Try to accomplish as many as 
possible. The more feedback obtained, the better. 
 Analyze feedback, begin redesigning prototype tending to 
feedback and suggestions 
 
o Week 5:  
 Mechanical and electrical engineering students continue and finalize 
design modifications based on feedback.  
 Produce an updated prototype, by 3D printer, or whatever the chosen 
method was. 
 While redesign is taking place, management engineering student arranges 
meeting times with the previously contacted biomedical engineers, for 
second round of validation. Enough time must be given to produce an 
updated prototype 
 Goals of Week 5: 
 Redesign previous prototype. 
 Obtain an updated physical rapid prototype. 
 Arrange meeting times with biomedical engineers for the following 
week for professional prototype analysis and feedback. 
 
o Week 6:  
 Finish the final meeting with biomedical engineers to obtain a professional 
evaluation of the prototype. 
 Analyze feedback, mechanical and electrical engineering students 
brainstorm to redesign based from the evaluation. 
 Management engineering will use the CAD files produced for the 
prototype to refigure a material and production cost. 
 Goals of Week 6: 
 Complete final meetings, obtain evaluation and feedback. 
 Apply evaluation to iteration of redesign. 
 Refigure rough material and production costs 
. 
o Week 7:  
 Last week of term. If meeting with end users or biomedical engineers 
haven’t been completed, this is the week to do so. 
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 Continue and finalize development of design and material costing.  
 Goal of Week 7: 
 Finish all meeting if need be. 
 Finalize design and materials costing. 
 
 B-term: October 25-December 15 
o Week 1 & 2:  
 Meet with Todd Keiller, have the prototype evaluated. 
 Complete any legal filings or further documentation needed to apply for a 
utility patent. This process will take 5-6 weeks to be completed. 
 Goals of Week 1 & 2: 
 Meet with Todd Keiller. 
 Accomplish all documentation needed to obtain a utility patent. 
The patent must be finished and obtained by the start of C-term 
 
o Week 3,4, 5, 6, 7:  
 Research electrocardiogram manufacturers who are potential licensing 
partners. 
 Determine the pieces of information needed to market the idea of 
licensing. 
 Draft a marketing plan to achieve a licensing agreement based on the 
benefits of our device, and what value it can bring to the manufacturer.  
 It is likely that each potential manufacturer will have its own marketing 
plan. 
 Seek advice from advisors, as well as Todd Keiller, and 
marketing/business professors. Seek what sort of information should be 
presented, and how the team should accomplish making contact with the 
right people. 
 Contact Todd Keiller to assure the utility patent will be owned by the start 
of C-term 
 
 Goals: 
 Have a finalized marketing plan(s) completed by the end of the 
term. This plan must be complete before any manufacturer is 
contact, being that sometimes a sales pitch needs to be given 
within the first 30 seconds to the right person on the phone in order 
to progress any further. 
 Have a completed and owned utility patent by the beginning of C-
term. 
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 C-term: January 12-February 3 
o No week to week criteria on the fact that obtaining a business agreement such as 
licensing can be a complex and long process. 
 The marketing plan must be completely second nature to every group 
member. Calls cannot be made to manufacturers if this is not the case. 
Confidence is key. 
 Manufacturers must be contacted. The way in which a company will go 
about doing this sort of business varies greatly. 
 How the group handles all forms of communication, the second the first 
manufacturer is called, must be dynamic, which the group must be flexible 
to.  
 Through the process of obtaining the agreement, advice should be sought 
by professors to better adapt in order to be successful. 
 If a company declines, mistakes will be corrected, and the process will 
start all over with a new potential manufacturer. 
 Goals: 
 Successfully execute the devised marketing plans to ultimately 
obtain a non-exclusive licensing agreement with a manufacturer. 
 If a manufacturer is tried, but fails, a main goal is to take the 
experience and reasons of failure and translate them into a better 
plan. 
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5.0 Gantt Chart 
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Appendix B: Provisional Patent 
 
Retractable EKG Wiring Unit 
 
 
BACKGROUND 
1. Background 
 
 The use of an electrocardiogram machine is a time sensitive test reading that can 
be critically important in helping direct medical professionals into the next step of a 
patient's prognosis. The faster a patient with a cardiac or respiratory issue can complete 
an EKG test, the more likely the medical staff can ensure a person's health.  
 
SUMMARY 
[001]  In the medical setting, organization and accessibility are crucial to maintaining 
efficient operations and a safe cleanly area. Machines and resources are shared within 
hospital settings and require convenient and accessible configurations for the end 
users. As most wired devices do, the electrocardiogram wires become tangled, 
unorganized and less accessible to our end users. This takes time away from the 
evaluation of patients and the next step in cardio-vascular care.  
 
[002] Whenever a patient has any symptoms or has trouble breathing, chest pains or a 
history of hereditary heart disease, an EKG test is usually called for. This accounts for 
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many instances where an electrocardiogram test will be necessary increasing the need 
for an organized device  
  
[003] A retractable wiring unit will solve these problems by allowing for the electrode 
leads to be wound up into the storage accessory, maintaining consistent organization, 
as well as simultaneous sanitation, for a convenient set-up process for future use 
 
 
BRIEF DESCRIPTION OF THE DRAWINGS 
[004] The present disclosure is further described in the detailed description which follows, 
in reference to the noted plurality of drawings by way of non-limiting examples of exemplary 
embodiments, in which like reference numerals represent similar parts throughout the several 
views of the drawings, and wherein: 
[005] FIG. 1 illustrates an exploded design of the wiring unit; 
[006] FIG. 2 illustrates the assembled design of the wiring unit; 
 
While the above-identified drawings set forth presently disclosed embodiments, other 
embodiments are also contemplated, as noted in the discussion. This disclosure presents 
illustrative embodiments by way of representation and not limitation. Numerous other 
modifications and embodiments can be devised by those skilled in the art which fall within the 
scope and spirit of the principles of the presently disclosed embodiments. 
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DETAILED DESCRIPTION 
[007] The following description provides exemplary embodiments only, and is not intended 
to limit the scope, applicability, or configuration of the disclosure. Rather, the following 
description of the exemplary embodiments will provide those skilled in the art with an enabling 
description for implementing one or more exemplary embodiments. It will be understood that 
various changes may be made in the function and arrangement of elements without departing 
from the spirit and scope of the disclosure as set forth in the appended claims. 
 
[008] Referring to FIG 1, the exploded design shows the placement of each component, and how 
the components interact with each other. The device has 5 spools, that each hold two wires, to 
hold the 10 wires that consists of a 12 lead EKG. The spools are activated by pushing down a 
corresponding button on top of the spool to engage the spool with the crank screw used to 
provide radial motion to the spools. The front department of the device is a cavity that holds a 
sponge soaked with a sanitary agent. Each wire will be pulled through a slit in the sponge, 
wiping the wires as the get coiled into their corresponding spool. 
 
[009] Referring to FIG 2, the assembled design shows the complete assembly of how the 
components come together to function. There are 5 spools, each holding 2 wires, a crank shaft to 
rotate the spools, and a hand crank to activate the crank shaft. 
 
[010] Specific details are given in the description to provide a thorough 
understanding of the embodiments. However, it will be understood by one of ordinary skill in the 
art that the embodiments may be practiced without these specific details. For example, systems, 
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processes, and other elements in the instant disclosure may be shown as components in block 
diagram form in order not to obscure the embodiments in unnecessary detail. In other instances, 
well-known processes, structures, and techniques may be shown without unnecessary detail in 
order to avoid obscuring the embodiments. Further, like reference numbers and designations in 
the various drawings indicated like elements. 
Changes may be made, within the purview of the appended claims, as presently stated and as 
amended, without departing from the scope and spirit of the present disclosure in its aspects. 
Although the present disclosure has been described herein with reference to particular means, 
materials and embodiments, the present disclosure is not intended to be limited to the particulars 
disclosed herein; rather, the present disclosure extends to all functionally equivalent structures, 
methods and uses, such as are within the scope of the appended claims. 
 
[0012] What is claimed is: 
1. A method to assist the consistent storage quality of the lead wires of an electrocardiogram 
machine, along with a simultaneous action of sanitation to sanitize the wires when being 
wrapped into storage. 
2.  
ABSTRACT 
 
 When operating an electrocardiogram, it is a common problem found by end users that 
the organization of the electrode lead wires can get tangled, and impede the set up and put away 
time of the operation. The device allows for consist, organized storage by retracting the wires 
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into an organization unit, along with sanitizing the wires while being stored. By creating this 
method, hospitals can become more efficient in time use while administering an 
electrocardiogram test, and ultimately save on costs. of operation through the end user. 
 
 
Figure 1  
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Figure 2 
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Appendix C: Business Model Canvas  
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Appendix D: Surveys, Survey Results & Interview Questions 
 
WPI 2015- 2016 MQP: Survey  
Attila Kara 
Pat Finn 
Advisors: Karla Mendoza-Abarca, Frank Hoy 
Salutations. We are senior students from Worcester Polytechnic Institute conducting 
interviews for our Senior Master Qualifying Project. We would like to ask for your participation 
in a brief survey. The goal of our Survey is to try to get a basic understanding of your daily 
routine in your profession and some daily inconveniences you might face. We as a group are 
essentially searching for potential business/entrepreneurial opportunities within your work 
environment, and to test out hypotheses of potential products that we have already come up with. 
We will not be searching for personal information other than your full name, what facility you 
work at, and what department. Individual responses will not be published, but an overall 
consensus of the answers we have collected will. This research will also help us to write our final 
deliverables needed for our project. This is entirely voluntary, and if the decision is made to 
participate, if at any time you feel uncomfortable and would like to skip a question, or 
discontinue the survey, this is absolutely acceptable. We appreciate you for taking the time out of 
your schedule to fill this out. Thank you. 
 
Date: 
Name: 
Job Position: 
Years of experience: 
 
 What kinds of tools do you use every day that require maintenance? 
 
 How many EKGs do you take a day?  
 
 How long does it take to apply the electrodes on a patient?  
 
 How long does it take for a successful reading to take place? 
 
 How long does it take to store the wires/electrodes after use? 
 
 What is the sanitation process for an EKG machine? 
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Survey Results:  
These graphs are in direct correlation with the collected survey data. 
Graph A: (Question 2) How many EKG’s do you take a day? 
 
 
 
 
 
 
 
 
 
Graph B: (Sum of Questions 3, 4 & 5) Total Elapsed Time of Use 
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Typical End User Interview Questions 
 
Date: 
Name: 
Job Position: 
Years of experience: 
Contact email: 
Contact Cell: 
 
 
Getting to know the job position 
 What is your job description? 
 Who does your boss/ bosses consist of? 
 How are you able to purchase new equipment? 
o How much do you have to spend on new equipment if you are allowed to choose? 
o Whose decision is it for what new items are purchased? 
 
Getting to know the work day 
 What kinds of jobs/task do you need to do daily? 
o Relating to patient, not relating to patient. 
o What are the difficulties/ hardships of the task? Frustrations? 
 
What kinds of things are used daily? 
 What kinds of tools do you use every day that don’t require maintenance? 
 What kinds of tools do you use every day that require maintenance? 
o What kind of maintenance must be done? 
 What is the sanitation process for the tools used described above? 
 Is there a specific storage process?  
 How many EKGs do you take a day? Week? Patient #’s? 
 How long does an EKG take? (how long is it supposed to, how long does it actually?) 
o What’s the process? 
o What kind of data is written down and recorded? 
o how much does it cost to take an EKG? 
 What is the sanitation process for an EKG machine? 
 What is the storage process for an EKG machine? 
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Appendix E: Interview Results 
 
9 Registered Nurses from 3 Separate Hospitals (cardiology, emergency-room, pediatrics) 
 
 Predominantly 12 lead EKGs 
 Just about every nurse reports to a 
nurse manager as their boss. 
 Any time something new is wanted, 
the proper paperwork needs to be 
filled and submitted with a nurse 
manager. Paperwork is relayed to the 
purchasing agent for evaluation. 
 First thing done during a shift is to 
tend to the assigned patients and 
follow procedure regarding 
paperwork, and patient care. 
 
 
 EKGs were consistently estimated to 
be between 6-8 minutes, depending 
on how well the last person put away 
the machine. 
 Lead wires are always wiped down 
after administering the EKG test. 
 Storage is just wrapping the wires in 
an organized manner, and depends 
on how well the last person put away 
the machine. 
 Consistent complaints about having to 
untangle the lead wires 
 
 
 
 Biomedical Engineers 
 Work with technical side of products 
 Initiates conversation with competitors 
for better prices 
 Has a relationship with large 
companies, has leeway with prices 
based on other smaller items 
 Meet with purchasing committee’s 
and hospital management for decision 
making purposes of technology 
 Confirmed entry into market through 
direct sales is a very hard process 
 Some hospitals outsource their 
biomedical engineering teams to save 
money and regulate monthly budgets 
for supplies and available engineers 
 Insurance policies allow for constant 
monthly costs for the outsourced 
engineering teams  
 Biomedical Engineers trouble shoot 
malfunctioning devices and 
equipment regularly 
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3 Purchasing Agents from 2 Separate Hospitals 
 Hierarchical decision making process 
 Every hospital has a different protocol 
for purchasing and improving 
additional technology and supplies 
 Value analysis committee evaluates 
the request, usually consisting of 
Board Members, and purchasing 
committee members 
 There are value analysis forms for 
employees to request new equipment 
or supplies. 
 Over 1,000$ considered capital 
equipment 
 Bio-Med would get involved with 
approving and advising orders 
 Compatibility to current equipment is 
a necessity 
 Companies have a stronghold on 
hospital sales 
 Vendors are put through a deliberate 
process before there company is 
considered for business 
 
 
 
Nurse Educator & Nurse Manager 
 
 Processes requests for new 
technology or supplies 
 Vendors are not met with normally in 
the hospital setting 
 EKG machines and other equipment 
are shared throughout the floor 
 
 
 Educate staff on proper use of 
machinery 
 Encouraged us to speak with 
biomedical engineers and purchasing 
department. 
 Important time protocols are taught 
and followed with each diagnostic 
technology.  
 
